|
Goodman & Gilman's The Pharmacological Basis of Therapeutics, 11e
7/28/2010: Pediatric Pharmacotherapy Part 1: The History of Pediatric Drug Therapy: Learning from Errors, Not Trials
Marcel J. Casavant
Chief, Pharmacology/Toxicology, Nationwide Children's Hospital, Medical Director, Central Ohio Poison Center, Clinical Professor, The Ohio State University Colleges of Medicine and Pharmacy
Jill R. K. Griffith
Clinical Pharmacist, Mount Carmel West Hospital, Clinical Assistant Professor, The Ohio State University College of Pharmacy
Topics Discussed: american pharmacy; benzyl alcohol; best pharmaceuticals for children act; drug design and development; ethical issues related to development, promotion, sales, prescribing, and use of drugs; fda modernization act of 1997; fda-mandated drug development; federal food, drug, and cosmetic act; glucuronosyltransferase; gray syndrome from chloramphenicol administration in newborn; kernicterus; legislation; legislation, drug; pediatric pharmacotherapy; pharmacotherapy; sulfanilamides; sulfisoxazole; united states food and drug administration.
Related to Chapter 5. The Science of Drug Therapy; View in chapter;
Excerpt:
"View in chapter..."
|
|
|
|
|